Memantine HCl  Tablets

10 & 20 mg

central nervous system


Memantine is indicated for the treatment of moderate to severe Alzheimer’s Disease (AD).
Unipharm’s generic Memantine HCl Tablets have been manufactured and marketed in Israel since 2006.

  • ATC4: N06DX
  • Strengths: 10 & 20 mg
  • Dosage form: Tablets
  • Out-licensing is offered for all international markets*
  • Zone IVb stability data is available
* Product availability is subject to patent restrictions in countries where applicable patents are in effect

related products